1425PD - Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
- Resource Type
- Abstract
- Source
- In
Annals of Oncology 1 October 2016 27 Supplement 6:vi493-vi493 - Subject
- Language
- ISSN
- 0923-7534